ÂÜÀòÂÒÂ×

Torsten Fauth's work experience begins in 2010 with their role as a Medical Writer at CDM World Agency in Munich, Germany. From there, they moved on to BRAIN Biotech AG, where they held various roles including Research Scientist / Project Manager from October 2010 to December 2014, Tech Specialist from January 2015 to December 2019, Tech Platform Head - BioActives Target Validation from January 2020 to June 2023, and currently serves as the Akribion Genomics Project Lead Cell Culture Genome Editing.

Torsten Fauth received their Bachelor's degree in Biology from Ulm University in 2004. Torsten then went on to pursue a PhD in Cell/Cellular Biology and Molecular Biology at Ludwig-Maximilians-Universität München, which they completed in 2010. In 2004, they also served as a Research Scholar at the University of North Carolina at Greensboro, focusing on Molecular Endocrinology.